Technology | 2019.09.09
NKMax America Announces New cGMP Manufacturing Facility for Production of SNK Cell Therapy
SANTA ANA, Calif., Sept. 9, 2019 /PRNewswire/ -- NKMax America, a biotechnology company harnessing the power of the body\'s immune system through the development of Natural Killer (NK) cell therapies, today announced that it has completed construction on its new 25,000 square foot,...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]nk-cell-therapy-300914331.html
Follow us on
📊 Most Viewed News
- • The complete guide to making your product international - The Nex... (15,542)
- • Colaboração 2.0: Breaking Down the Language Barrier - Business ... (12,035)
- • A Start-Up Bets on Human Translators Over Machines - New York Tim... (11,530)
- • Immigrants 'should learn English' - Politics.co.uk (11,211)
- • How OpenStack gets translated - opensource.com (11,048)
- • easyJet Chooses TransPerfect for Pan-European Translation - Busin... (10,937)
- • Para-Plus Translations Honored by Philadelphia Business Journal .... (10,367)
- • Google Adds Customized Translations for Website Owners - PC Magaz... (10,257)